[Anti-TNF alpha therapy: a risk factor for legionella infection]

Rev Mal Respir. 2007 Nov;24(9):1159-60. doi: 10.1016/s0761-8425(07)74271-7.
[Article in French]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Etanercept
  • Humans
  • Immunoglobulin G / administration & dosage
  • Immunoglobulin G / adverse effects*
  • Legionellosis / diagnosis*
  • Male
  • Methotrexate / therapeutic use
  • Middle Aged
  • Opportunistic Infections / diagnosis*
  • Receptors, Tumor Necrosis Factor / administration & dosage
  • Risk Factors
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept
  • Methotrexate